A 60-year-old male presented with nine-month history of pain and progressively increasing swelling over the dorsomedial aspect of the right foot. It started as a small painful swelling over the dorsum of the foot. The patient developed a non-healing fungating ulcer at the biopsy site during the course of disease (Figures 1a and b) . There was no history of trauma, fever or discharging sinus, and no history of any other swelling in the body. There was no history of radiation exposure. The patient was non-diabetic and did not present with any other systemic ailment. On examination, a diffuse, hard swelling about 10×15 cm was present over the dorsomedial aspect of the right foot. A fungating ulcer, about 4×4 cm in size, was present over the swelling. There was full range of motion of the ankle. Examination of the chest and abdomen was normal.
Introduction
Primary leiomyosarcoma of bone is a rare tumour. 1 Its most common location is in the metaphyseal region of the long bones, predominantly the femur and tibia. 2 We report a case of primary leiomyosarcoma of first metatarsal, which to our knowledge, has never been reported at this site.
Case report
A 60-year-old male presented with nine-month history of pain and progressively increasing swelling over the dorsomedial aspect of the right foot. It started as a small painful swelling over the dorsum of the foot. The patient developed a non-healing fungating ulcer at the biopsy site during the course of disease (Figures 1a and b) . There was no history of trauma, fever or discharging sinus, and no history of any other swelling in the body. There was no history of radiation exposure. The patient was non-diabetic and did not present with any other systemic ailment. On examination, a diffuse, hard swelling about 10×15 cm was present over the dorsomedial aspect of the right foot. A fungating ulcer, about 4×4 cm in size, was present over the swelling. There was full range of motion of the ankle. Examination of the chest and abdomen was normal.
Plain radiograph of the foot showed a poorly defined lytic lesion with complete destruction of the first metatarsal bone extending into the surrounding tissues, second metatarsal, medial and middle cuneiform (Figure 2) . studies have described expression of smooth muscle actin (SMA), desmin, or vimentin in an objective identification of smooth muscle origin. 2, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 15, 18, 19 Electron microscopy showed definite smooth muscle differentiation including cytoplasmic filaments with dense bodies, basement membranes and pinocytotic vesicles. 4, 5, 7, 8, 11, 12, 18 According to Young, immunohistochemistry allows the histological diagnosis to be made without the need to resort to ultrastructural studies. 5 The differential diagnosis on histology includes fibrosarcoma, malignant fibrous histiocytoma, myofibrosarcoma, metastatic carcinoma and osteosarcoma. 15, 20 The microscopy in the present case showed eosinophilic spindle cells with vesicular, ovoid to cigar-shaped nuclei, arranged in fascicles. The tumour cells showed high mitotic activity with necrotic areas. Immunohistochemistry showed focal positive staining to SMA and diffuse positive staining to vimentin in tumour cells.
Surgical is the treatment of choice for leiomyosarcoma of bone. Surgical excision with wide margins remains the gold standard for curative management. Chemotherapy, either neoadjuvant or adjuvant, and radiotherapy do not provide an improved prognosis over a simple ablative surgical procedure. 8, 11, 14, 15 We planned for below-knee amputation to obtain wide, tumour-free margins.
Conclusion
Primary leiomyosarcoma of bone is rare and should be kept in the differential diagnosis of primary malignant osteolytic, destructive neoplasms, especially in the older age group. Vascular leiomyosarcoma of peripheral veins is another rare possibility although more common sites are inferior vena cava, pulmonary arteries and iliac veins. 21, 22 Histopathology evaluation with immunohistochemistry analysis is helpful in reaching the accurate diagnosis. Treatment is primarily surgical with limited benefit from neoadjuvant and adjuvant therapies.
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